NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors
Ontology highlight
ABSTRACT: NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors
PROVIDER: PRJNA1143539 | ENA |
REPOSITORIES: ENA
ACCESS DATA